St. Jude Medical (STJ) Lowers Q3 Adj-EPS Outlook Below the Street
Tweet Send to a Friend
St. Jude Medical, Inc. (NYSE: STJ) sees lower than expected Q3 sales at about $1.159 billion, which compares to the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
